Skip to main content
Clinical Trials/NCT02123355
NCT02123355
Unknown
Phase 4

The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery,A Randomized Controlled Study

Shaanxi Provincial People's Hospital0 sites80 target enrollmentAugust 2014

Overview

Phase
Phase 4
Intervention
Induction of anesthesia
Conditions
Cognitive Ability, General
Sponsor
Shaanxi Provincial People's Hospital
Enrollment
80
Primary Endpoint
Change from baseline in cognitive function at 7 days
Last Updated
12 years ago

Overview

Brief Summary

The incidence of postoperative cognitive dysfunction (POCD) is high and POCD affect the life quality and the prognosis of patients. Geriatrics is the independent risk factor of POCD, and POCD is also correlated with many other factors such as type of surgery, the duration of anesthesia and the anesthesia drugs used et al. So, the prevention and treatment of POCD in geriatrics is important.

Dexmedetomidine is found to have the effect of neuro-protection, but it is controversy whether Dexmedetomidine has the effect of neuro-protection in geriatrics, especially the prolonged surgery.

The purpose of this study is to explore the effect of Dexmedetomidine to the cognitive function at prolonged surgery in geriatrics in geriatrics.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
August 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yang Li

Anesthesiologist

Shaanxi Provincial People's Hospital

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • Scheduled for elective abdominal surgery
  • Weight is within the range of ±20% of standard weight \[standard weight=Height(cm)-80)×70﹪ for male and(Height(cm)-70)×60﹪\] for female
  • American society of anesthesia classification I\~III
  • Expected time of surgery is more than 4 hours -

Exclusion Criteria

  • Systolic blood pressure≥180 mm Hg or \<90 mm Hg,diastolic blood pressure≥110 mm Hg or \< 60 mm Hg;
  • Serious cardiac,liver,kidney,lung, endocrine disease or sepsis.
  • Allergy to trial drug or other contraindication;
  • Difficult airway occurred before,or difficult airway possibly occurred and difficult to extubation
  • History of mental illness and cerebral vascular disease
  • History of unstable angina or myocardial infarction
  • Education level\<7 yrs
  • Factors existed that affect cognition assessment such as language, visual sense,auditory sense disorders.
  • Abuse of narcotic analgesia or suspected;
  • Neuromuscular diseases;

Arms & Interventions

Dexmedetomidine

Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Induction of anesthesia

Dexmedetomidine

Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Intubation

Dexmedetomidine

Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Sevoflurane, remifentanil ,vecuronium

Dexmedetomidine

Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Dexmedetomidine

Normal saline

Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Induction of anesthesia

Normal saline

Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Intubation

Normal saline

Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Sevoflurane, remifentanil ,vecuronium

Normal saline

Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Intervention: Placebo

Outcomes

Primary Outcomes

Change from baseline in cognitive function at 7 days

Time Frame: Baseline, the 7th day after the surgery

1. Modified Newman scale to assess the cognitive function, including five tests. 2. The quiet environment, enough daylight, no disturb is needed when the modified Newman scale is done. All the five tests are finished within 30 min. 3. all the score of each test of all the patients assessed before the surgery is calculated, then get the standard variation, the score of each subject of each test is compared with the standard deviation, if one or more stand deviation decrease, then the cognitive function is considered as deterioration . 4. When 2 or more of the tests is considered as deterioration, then the patients is diagnosed as Post Operation Cognitive Dysfunction (POCD).

Secondary Outcomes

  • Inflammatory responsive assessment(From entering the operating room to 48 hours after the surgery)
  • Brain injury assessment(From entering the operating room to 48 hours after the surgery)
  • Depth of anesthesia(From the induction of anesthesia to the right moment of extubation, up to 1 day.)
  • Recovery of anesthesia(From the induction of anesthesia to the right moment of extubation, up to 1 day.)
  • Respiration rate(From the induction of anesthesia to the right moment of extubation, up to 1 day.)
  • Pulse blood oxygen saturation(From the induction of anesthesia to the right moment of extubation, up to 1 day.)
  • Number of Participants with Serious and Non-Serious Adverse Events(Up to 7 days)
  • Heart rate(From the induction of anesthesia to the right moment of extubation, up to 1 day.)
  • Central venous pressure(CVP)(From the induction of anesthesia to the right moment of extubation, up to 1 day.)
  • Blood pressure(From the induction of anesthesia to the right moment of extubation, up to 1 day.)

Similar Trials